Lattice Biologics' Reverse Merger Round

Lattice Biologics raised a round of funding on August 06, 2015. Investors include Blackstone Ventures.

Lattice Biologics specializes in the field of cellular therapies and tissue engineering, with a focus on bone, skin, and cartilage regeneration. Lattice develops and processes biologic allograft produ…

Articles about Lattice Biologics' Reverse Merger Round: